Treatment of acute coronary syndrome: part 2: ST-segment elevation myocardial infarction
- PMID: 22610195
- DOI: 10.1097/CCM.0b013e31824e18c2
Treatment of acute coronary syndrome: part 2: ST-segment elevation myocardial infarction
Abstract
Objective: Familiarize clinicians with recent information regarding the diagnosis and treatment of ST-segment elevation myocardial infarction.
Data sources: PubMed search and review of relevant medical literature.
Summary: Definition, pathophysiology, clinical presentation, diagnosis, and treatment of ST-segment elevation myocardial infarction are reviewed.
Conclusions: Patients with ST-segment elevation myocardial infarction benefit from prompt reperfusion therapy. Adjunctive antianginal, antiplatelet, antithrombotic, beta blocker, angiotensin-converting enzyme inhibitor, and statin agents minimize ongoing cardiac ischemia, prevent thrombus propagation, and reduce the risk of recurrent cardiovascular events.
Similar articles
-
Treatment of acute coronary syndrome: Part 1: Non-ST-segment acute coronary syndrome.Crit Care Med. 2011 Oct;39(10):2346-53. doi: 10.1097/CCM.0b013e31821e855f. Crit Care Med. 2011. PMID: 21602671 Review.
-
Modern management of acute myocardial infarction.Curr Probl Cardiol. 2012 Jul;37(7):237-310. doi: 10.1016/j.cpcardiol.2012.03.002. Curr Probl Cardiol. 2012. PMID: 22664306 Review.
-
Oral antiplatelet therapy in unstable angina/non-ST-segment elevation myocardial infarction, ST-segment elevation myocardial infarction, and percutaneous coronary intervention: is it time for a guideline update?Am J Cardiol. 2009 Sep 7;104(5 Suppl):4C-8C. doi: 10.1016/j.amjcard.2009.06.019. Am J Cardiol. 2009. PMID: 19695354 Review.
-
[Indications for urgent coronary angiography. Part I: ST-segment elevation acute coronary syndromes].Rev Med Suisse. 2009 May 27;5(205):1195-6, 1198-201. Rev Med Suisse. 2009. PMID: 19517751 Review. French.
-
Strategies and Therapies for Reducing Ischemic and Vascular Events (STRIVE): updated standing orders for ST-segment elevation myocardial infarction and unstable angina/non-ST-segment elevation myocardial infarction.Crit Pathw Cardiol. 2010 Jun;9(2):55-81. doi: 10.1097/HPC.0b013e3181dfd6f8. Crit Pathw Cardiol. 2010. PMID: 20520214 Review.
Cited by
-
The Association Between Hematologic Indices with TIMI Flow in STEMI Patients who Undergo Primary Percutaneous Coronary Intervention.Cardiovasc Hematol Disord Drug Targets. 2022;22(3):162-167. doi: 10.2174/1871529X22666220913122046. Cardiovasc Hematol Disord Drug Targets. 2022. PMID: 36100995
-
MIF mRNA Expression and Soluble Levels in Acute Coronary Syndrome.Cardiol Res Pract. 2018 Jul 2;2018:9635652. doi: 10.1155/2018/9635652. eCollection 2018. Cardiol Res Pract. 2018. PMID: 30057807 Free PMC article.
-
Establishment and validation of a risk model for prediction of in-hospital mortality in patients with acute ST-elevation myocardial infarction after primary PCI.BMC Cardiovasc Disord. 2020 Dec 9;20(1):513. doi: 10.1186/s12872-020-01804-7. BMC Cardiovasc Disord. 2020. PMID: 33297955 Free PMC article.
-
Development of a nomogram for the prediction of in-hospital mortality in patients with acute ST-elevation myocardial infarction after primary percutaneous coronary intervention: a multicentre, retrospective, observational study in Hebei province, China.BMJ Open. 2022 Feb 2;12(2):e056101. doi: 10.1136/bmjopen-2021-056101. BMJ Open. 2022. PMID: 35110324 Free PMC article.
-
The role of COX2 deficiency attenuates cardiac damage in acute myocardial infarction.BMC Cardiovasc Disord. 2024 Nov 7;24(1):623. doi: 10.1186/s12872-024-04233-y. BMC Cardiovasc Disord. 2024. PMID: 39511505 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
